CHM chimeric therapeutics limited

funder

  1. 2,243 Posts.
    we have made numerous requests to Chameleon and various regulatory
    agencies for more detailed disclosure of Chameleon's litigation funding
    arrangements as we believe those arrangements are very material given
    Chameleon's financial position. The only information we have been able
    to establish is that the funder is Paul Lindholm.

    Two tranches of security for costs have been provided. The third is
    currently being negotiated.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
-0.001(10.0%)
Mkt cap ! $9.068M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $2.056K 411.4K

Buyers (Bids)

No. Vol. Price($)
47 26967650 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 5217011 2
View Market Depth
Last trade - 15.39pm 22/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.